View in EDS HTML Full Text PDF Full Text

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Authors: Taşçı, Elif Şenocak1 (AUTHOR) esenocak@gmail.com, Oyan, Başak2 (AUTHOR), Sönmez, Özlem2 (AUTHOR), Mutlu, Arda Ulaş2 (AUTHOR), Atcı, Muhammed Mustafa3 (AUTHOR), Sakin, Abdullah4 (AUTHOR), Öner, İrem5 (AUTHOR), Çınkır, Havva Yeşil6 (AUTHOR), Eryılmaz, Melek Karakurt7 (AUTHOR), Çağlayan, Dilek7 (AUTHOR), Balçık, Onur Yazdan8 (AUTHOR), Paksoy, Nail9 (AUTHOR), Karabulut, Senem10 (AUTHOR), Salim, Derya Kıvrak11 (AUTHOR), Bilir, Cemil12 (AUTHOR), Özen, Miraç13 (AUTHOR), Özçelik, Melike14 (AUTHOR), Arıcan, Ali2 (AUTHOR), Akagündüz, Baran15 (AUTHOR), İnal, Ali16 (AUTHOR)
Source: BMC Cancer. 1/22/2024, Vol. 24 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-023-11783-5